Jinnin M - Search Results

1

Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia.

Takamatsu K, Nakane S, Suzuki S, Kosaka T, Fukushima S, Kimura T, Miyashita A, Mukaino A, Yamakawa S, Watanabe K, Jinnin M, Komohara Y, Ihn H, Ando Y. Takamatsu K, et al. Among authors: jinnin m. Ann Clin Transl Neurol. 2018 Sep 23;5(11):1421-1427. doi: 10.1002/acn3.654. eCollection 2018 Nov. Ann Clin Transl Neurol. 2018. PMID: 30480036 Free PMC article.

2

A case of linear scleroderma with muscle calcification.

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Jinnin M, et al. Br J Dermatol. 2002 Jun;146(6):1084-6. doi: 10.1046/j.1365-2133.2002.04676.x. Br J Dermatol. 2002. PMID: 12072084

3

Serum levels of tissue inhibitor of metalloproteinases in patients with mixed connective tissue disease.

Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Jinnin M, et al. Clin Exp Rheumatol. 2002 Jul-Aug;20(4):539-42. Clin Exp Rheumatol. 2002. PMID: 12175110

4

Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease.

Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N, Fujimoto M, Tamaki K. Ihn H, et al. Among authors: jinnin m. Rheumatology (Oxford). 2002 Nov;41(11):1268-72. doi: 10.1093/rheumatology/41.11.1268. Rheumatology (Oxford). 2002. PMID: 12421999

5

Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension.

Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Jinnin M, et al. Rheumatology (Oxford). 2003 Feb;42(2):240-3. doi: 10.1093/rheumatology/keg071. Rheumatology (Oxford). 2003. PMID: 12595617

6

Elevated circulating soluble CD40 ligand in patients with mixed connective tissue disease.

Jinnin M, Ihn H, Yazawa N, Asano Y, Yamane K, Tamaki K. Jinnin M, et al. Clin Rheumatol. 2003 Feb;22(1):37-9. doi: 10.1007/s10067-002-0669-y. Clin Rheumatol. 2003. PMID: 12605316

7

Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis.

Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Jinnin M, et al. Clin Exp Rheumatol. 2003 Jan-Feb;21(1):91-4. Clin Exp Rheumatol. 2003. PMID: 12673896

8

Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.

Yamane K, Ihn H, Asano Y, Jinnin M, Tamaki K. Yamane K, et al. Among authors: jinnin m. J Immunol. 2003 Oct 1;171(7):3855-62. doi: 10.4049/jimmunol.171.7.3855. J Immunol. 2003. PMID: 14500687

9

Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.

Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Jinnin M, et al. Oncogene. 2004 Mar 4;23(9):1656-67. doi: 10.1038/sj.onc.1207064. Oncogene. 2004. PMID: 15001984

10

Serum matrix metalloproteinase-3 in systemic sclerosis.

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Jinnin M, et al. Arch Dermatol Res. 2004 Jun;296(1):25-9. doi: 10.1007/s00403-004-0468-1. Epub 2004 Apr 17. Arch Dermatol Res. 2004. PMID: 15095096

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters